Qelbree (Viloxazine)
- Medicine Name: Qelbree
- Generic Name: Viloxazine
- Dosage Form & Strength: Capsules: 100 mg, 150 mg and 200 mg
- Manufactured By: Supernus Pharmaceuticals, Inc.
Qelbree (Viloxazine 100 mg, 150 mg and 200 mg) is a selective norepinephrine reuptake inhibitor widely used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older.
Recommended Dosage: Administer this medicine orally with or without food. Do not chew, cut, or crush the capsules. Swallow capsules, or open them and sprinkle the whole contents over a tablespoonful or teaspoonful of pudding/applesauce. Consume the food mixture in its entirety, without chewing, within 15 minutes for pudding, or within a couple of hours for applesauce; avoid storing it for future use.
Pediatric patients: The recommended starting dosage of Qelbree capsules for pediatric patients 6-11 years of age is 100 mg by mouth (orally) once daily. Dosage can be titrated in increments of 100 mg at weekly intervals to the maximum dosage of 400 mg once in day, on behalf of response and tolerability. The recommended starting dosage for pediatric patients 12-17 years of age is 200 mg by mouth (orally) once a day. After 7 days (1 week), dosage can be titrated by an increment of 200 mg to the maximum dosage of 400 mg once in a day, on behalf of response and tolerability.
Adult patients: The recommended starting dosage of Qelbree capsules for adults is 200 mg orally once a day. Dosage can be titrated in increments of 200 mg weekly to the maximum dosage of 600 mg once a day, on behalf of response and tolerability. Pharmacological treatment of attention deficit hyperactivity disorder may be required for extended periods. Periodically reevaluate the long-term use of Qelbree and adjust dosage as required.
- Evaluate heart rate and blood pressure prior to initiating treatment with Qelbree 100 mg, 150 mg, 200 mg Capsules, following increases in Qelbree dosage, and periodically throughout the therapy.
- Before initiating treatment with Viloxazine Capsules: 100 mg, 150 mg, 200 mg, screen patients for a personal or family history of bipolar disorder, suicide, and depression.
- Higher rates of suicidal thoughts/behaviors were reported in both pediatric and adult patients with ADHD treated with Viloxazine. Closely assess patients for clinical worsening and emergence of suicidal thoughts/behaviors.
- Therapy with Viloxazine 100 mg, 150 mg, 200 mg capsules can cause an increase in heart rate and diastolic blood pressure. Evaluate heart rate and blood pressure before starting treatment with Viloxazine, following increases in dosage, and periodically throughout the therapy.
- Noradrenergic medicines, such as Qelbree, may induce a manic or mixed episode in those with bipolar disorder. Prior to starting treatment, screen patients to specify if they are at risk for bipolar disorder.
- Qelbree can be responsible for causing fatigue and somnolence. Respective patients should not perform activities requiring mental alertness, such as operating a motor vehicle or operating any machinery until they know how they will be affected by medicine.
- Viloxazine may be responsible for causing maternal harm if used during pregnancy. Discontinue treatment if pregnancy is recognized unless the benefits of therapy outweigh the potential risk to the mother.
What documents are required to import QELBREE to India?
QELBREE (viloxazine) capsules can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:
- Valid prescription from a qualified doctor.
- Patient’s diagnostic reports
- Patient’s Identity Proof (issued by the government of India)
How does the order be confirmed?
The order will be confirmed only after the receipt of:
- Valid prescription from the Doctor
- Import permit if applicable
Is QELBREE available in India?
QELBREE (viloxazine capsule) is a prescription drug that legally requires a medical prescription to be dispensed.
Urgent Meds helps import cancer medicines on the named patient supply (NPS). Urgent Meds is the facilitator providing input on:
- Availability of Qelbree in India (Hyderabad, Chennai, Mumbai, Kolkata, Ahmedabad, Delhi, Bangalore, Pune, etc.)
- Medicine Price.
- Finding genuine and reliable sources from Canada, Europe, USA, and Australia
- Ensuring 100% transparency.
QELBREE can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Pune, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
Urgent Meds can facilitate the supply of QELBREE (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Urgent Meds is able to source the QELBREE (Cancer Treatment Medicines) from across the globe and has the ability to supply. Urgent Meds offers its customers worldwide access to the best available treatment.
Urgent Meds is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Qelbree®?
Viloxazine is the Generic Name for the trade name drug Qelbree®.
What is the Manufacturer Name of Qelbree®?
Qelbree® is manufactured by Supernus Pharmaceuticals, Inc.
Is Qelbree® approved by the FDA?
Yes, Qelbree® is approved by the FDA. Date of first/initial approval: April 2, 2021.
What is the dosage and form of Qelbree® supplied?
Qelbree® is supplied as Capsules: 100 mg, 150 mg, and 200 mg for oral administration.
Where can I get Qelbree® capsule at the best price in India?
To get the best Qelbree price in India, kindly contact Urgent Meds (a WHO GDP & ISO 9001: 2008 certified company). For Qelbree®, a valid medical prescription is required from your treating physician.
What are the most common side effects of Qelbree®?
The most common side effects of Qelbree in pediatric patients 6 to 17 years of age are somnolence, decreased appetite, fatigue, nausea, vomiting, insomnia, and irritability.
The most common side effects of Qelbree in adult patients are nausea, fatigue, decreased appetite, somnolence, dry mouth, insomnia, headache, and constipation.
How much does Qelbree® cost in India?
The Qelbree cost in India can vary. In order to procure this ADHD medication authentically, you can call or WhatsApp +1-647-818-4196 or send mail to info@urgentmeds.in.
What are the storage conditions of Qelbree®?
Store Qelbree at a temperature of 20°C to 25°C (68°F to 77°F); excursions are permitted between 15°C to 30°C (59°F to 86°F).
Is it safe to buy Qelbree® capsules online from India?
Yes, you can buy Qelbree capsules online at the best price from Urgent Meds if Qelbree has not been approved or is unavailable in your home country.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.